McGill researchers uncover crucial link between hippocampus and prefrontal cortex

16-08-2012

A clue to understanding certain cognitive and mental disorders may involve two parts of the brain which were previously thought to have independent functions, according to a McGill University team of researchers led by Prof. Yogita Chudasama, of the Laboratory of Brain and Behavior, ...

more

09-08-2012

Cynapsus Therapeutics Inc. announced that it has been awarded a grant of USD$947,925 from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to support clinical studies to develop APL-130277, a sublingual (oral) thin film strip reformulation of apomorphine. Apomorphine is an ...

more

06-08-2012

Caffeine, which is widely consumed around the world in coffee, tea and soft drinks, may help control movement in people suffering from Parkinson's. This is the finding of a study conducted at the Research Institute of the McGill University Health Centre (RI MUHC) that was recently published ...

more

Canadian Cancer Society grants new funding

27-07-2012

Two Ottawa researchers are taking innovative approaches to improving virus-based cancer therapy with new funding from the Canadian Cancer Society. Viruses that selectively target and kill cancer cells — called oncolytic viruses — are an exciting new avenue for treating cancer because healthy ...

more

19-06-2012

Dalton Pharma Services announced that the company has received GLP certification from The Standards Council of Canada.SCC accreditation is recognized around the globe. In Canada, SCC administers the OECD GLP initiative. OECD (Organization for Economic Development and Co-operation) has 34 ...

more

09-05-2012

University of British Columbia researchers have found a potential way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations. Led by Prof. John Schrader, Canada Research Chair in Immunology and director of UBC's Biomedical Research Centre, the research team ...

more

Collaboration with the GU Radiation Oncology Group of Quebec and the Segal Cancer Centre at the Jewish General Hospital (JGH)

02-05-2012

Sanofi Canada is supporting a five-year study on radiation therapy and prostate cancer. Dr. Tamim Niazi of the Quebec Radiation Oncology GU Group and the JGH is the lead researcher. Sanofi Canada President and CEO, Hugh O'Neill and members of Sanofi's Oncology Team celebrate the collaboration.

more

Researchers discover resistance in freshwater systems throughout Ontario

27-04-2012

The author Dr. Seuss may have been on to something when he imagined that microscopic communities could live and flourish on small specs of dust, barely visible to the naked eye. In fact, such vibrant communities exist – in a material with a Seussical sounding, yet scientific name called ...

more

Research on stickleback fish shows how adaptation to new environments involves many genes

04-04-2012

A current controversy raging in evolutionary biology is whether adaptation to new environments is the result of many genes, each of relatively small effect, or just a few genes of large effect. A new study published in Molecular Ecology strongly supports the first "many-small" ...

more

03-04-2012

Scientists at the University of Guelph have found a way to successfully clone American elm trees that have survived repeated epidemics of their biggest killer — Dutch elm disease.The breakthrough, published in the Canadian Journal of Forest Research, is the first known use of in vitro culture ...

more